… Recent studies have identified that the signals driving CD8 T-cell memory formation and
retention in vitiligo were associated with relapse of vitiligo, 18 ,19 which might explain our …

… represent a new treatment option for vitiligo, a condition … for vitiligo. Our findings support
previous reports hypothesizing that JAK inhibition is a promising new treatment option for vitiligo …

… In 2012, the most recent and approved classification for Vitiligo was given at Vitiligo
Global Issues Consensus Conference (VGICC). Understanding the biological mediators and …

… consensus in 2011 recognized non-segmental vitiligo (NSV) and segmental vitiligo (SV) as
… It was decided to use the term "vitiligo" to refer to all non-segmental vitiligo types. One of the …

… recommendations on the use of talimogene laherparepvec monotherapy in patients with
melanoma in Europe… therapy: consensus statements for best practices in administration from the …

… Those with vitiligo lack melanin in affected white patches of skin. It is, therefore, understandable
that dermatologists around the world have been concerned about the development of …

… from a subsample by clinicians experienced in vitiligo. However, only a small proportion (20.1%)
of patients submitted photographs, and vitiligo could not be verified in approximately 45…

… mofetil can be somewhat effective in the treatment of vitiligo; however, it seems to be inferior
… in the treatment of vitiligo. To our knowledge, there is no such study in the literature to date. …

… The present consensus provides an update to the 2017 European Dermatology Forum
Guidelines, … Part 1 of this consensus provides clinicians with an overview of the diagnosis and …

Vitiligo is the most common depigmentation disorder where the selective destruction of
functioning melanocytes causes depigmentation of the skin, hair and mucosal surfaces. It affects …